✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Alovudine is an investigational drug.
There have been 8 clinical trials for Alovudine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2004.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Immunologic Deficiency Syndromes. The leading clinical trial sponsors are National Cancer Institute (NCI), Lederle Laboratories, and Boehringer Ingelheim.
Recent Clinical Trials for Alovudine
|Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement||National Cancer Institute (NCI)||Phase 2|
|Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement||ECOG-ACRIN Cancer Research Group||Phase 2|
|Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy||National Cancer Institute (NCI)||Early Phase 1|